The major brands in China’s urinalysis market are URIT, DIRUI, AVE, etc. URIT produced China’s first urine analyzer in 1984. And after nearly 40 years’ strenuous cultivation, it pioneered the modular urine analysis workflow using deep learning artificial intelligence (AI) image recognition technology.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recently, Hotgen Coronavirus (2019-nCoV)-Antigentest has officially passed 3a validation of the UK Department of Health and Social Care (DHSC), which proves that the antigen test not only has high specificity, but also has high detection sensitivity.

UK-based startup Tailor Bio has received ￡650,000 ($771,767) through the Innovate UK Biomedical Catalyst Award in support of its ambitions to develop a pan-cancer precision medicine platform.

The National Comprehensive Cancer Network on Tuesday published new guidelines for treating children with brain cancer, underscoring the importance of broad molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for patients.

Recently, Shanghai University, relying on Shanghai's scientific and educational resources, gave full play to the cross-integration of multiple disciplines such as machinery and control, and the national first-class discipline of "mechanical engineering"

Biomarker discovery firm Sapient said Monday that it has received a $9.2 million grant from the Bill & Melinda Gates Foundation for mass spectrometry-based metabolomic biomarker studies.

Hologic and Thermo Fisher Scientific announced separately on Monday that they have received CE-IVD marking for their respective RT-PCR-based respiratory virus assays.

Zhiyan Consulting Data Center released the net profit ranking of Chinese medical device listed companies in the first quarter of 2022, ranking 109 Chinese listed medical companies according to their net profit in the first quarter of 2022.

Color Health said on Friday that it has partnered with the US Centers for Disease Control and Prevention to increase access to no-cost, PCR-based, COVID-19 testing.

Quest Diagnostics said Thursday that it is participating in the Centers for Disease Control and Prevention's (CDC) Increasing Community Access to Testing (ICATT) for COVID-19 program.

How did Chinese listed companies perform in the first half of the year? As of June 30, 2022, a total of 8,392 Chinese listed companies have been listed on 16 major exchanges in the world, including Shanghai, Shenzhen, Beijing, Hong Kong and New York.